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Background
The subcommissural organ (SCO) is a cerebral structure,
formed by an ependymal differentiation of the third ven-
tricle and is composed of two layers of cells: the ependy-
mal layer in contact with the ventricular light and the
hypendymal layer just below the posterior commissure
(PC). The subcommissural organ (SCO) functions are
associated with the circulation and composition of the
CSF, which secretes glycoprotein into the CSF where the
greater part is condensed and forms Reissner's fibre (RF),
and the other soluble minor part in the CSF. In the
human, the development of SCO is greatest during fetal
life and also produces glycoprotein but does not form RF.
Variations and alterations in the secretion of the SCO have
been described in hydrocephalus. p73 is a complex pro-
tein with a variety of isoforms, the transactivating iso-
forms (TA) are able to transactivate p53 gene target and
induce apoptosis, whereas the N-terminally truncated iso-
forms (ÄN) have anti-apoptotic activities. Immuno-blot-
ting of the choroid plexus and cerebrospinal fluid
revealed an N-glycosylated form of TAp73, which suggests
that p73 may be secreted. The aim of the present work is
to analyze the importance of the p73 expression during
the SCO human development.
Materials and methods
Brains from 10, 12, 21, 22, weeks of gestation, three
months postnatal and a 27 year old human, from the col-
lection of the Department of Anatomy of University of La
Laguna, were used. Brains were processed using the fol-
lowing standardized form: fixation in formaldehyde, post
fixation in Bouin's fluid for 24 hours, dehydration, and
paraffin embedding, thereafter were cut in three (A, B, and
C) coronal and sagittal sections 10 μm thick. The A series
were stained with Cresyl Violet or Klüver-Barrera. B and C
series were immunohistochemically processed using p73
as primary antibody.
Results
The immunoreactive material for anti-p73 was observed
at the fetal ages, and the reaction was more intense at 12
weeks in the ependymal layer. At 22 and 24 weeks of ges-
tation the p73 immunoreactive material was observed in
both cellular layers and even in the peripheral prolonga-
tion, but the intensity of the reaction decreased with
respect to the first ages. At three months and 27 postnatal
years the reaction is weaker than prenatal ages.
Conclusion
The greatest intensity of the reaction was observed at 10
weeks of gestation which coincides with the moment of
the greatest development of the human SCO.
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